Insights into the molecular determinants involved in cap recognition by the vaccinia virus D10 decapping enzyme

Nucleic Acids Research

Volumn 38, Issue 21, 2010, Pages 7599-7610

  Soulière, Marie F ^a   Perreault, Jean Pierre ^a   Bisaillon, Martin ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE; UNCLASSIFIED DRUG; VACCINIA VIRUS D10 DECAPPING ENZYME; VIRUS ENZYME;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; MOLECULAR DOCKING; MOLECULAR MODEL; MOLECULAR RECOGNITION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; VACCINIA VIRUS;

AMINO ACID SEQUENCE; CATALYTIC DOMAIN; DINUCLEOSIDE PHOSPHATES; ENDORIBONUCLEASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEOTIDASES; NUCLEOTIDES; PROTEIN BINDING; RNA CAPS; SCHIZOSACCHAROMYCES POMBE PROTEINS; VACCINIA VIRUS; VIRAL PROTEINS;

VACCINIA VIRUS;

EID: 78649827255     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq628     Document Type: Article

References (44)

1. Jackson, D. A., Pombo, A. and Iborra, F. (2000) The balance sheet for transcription: an analysis of nuclear RNA metabolism in mammalian cells. FASEB J., 14, 242-254.
2. Parker, R. and Sheth, U. (2007) P bodies and the control of mRNA translation and degradation. Mol. Cell., 25, 635-646.
3. Wickens, M. and Goldstrohm, A. (2003) A place to die, a place to sleep. Science, 300, 753-755.
4. Decker, C. J., Teixeira, D. and Parker, R. (2007) Edc3p and a glutamine/asparagine-rich domain of Lsm4p function in processing body assembly in Saccharomyces cerevisiae. J. Cell. Biol., 179, 437-449.
5. Hu, W., Sweet, T. J., Chamnongpol, S., Baker, K. E. and Coller, J. (2009) Co-translational mRNA decay in Saccharomyces cerevisiae. Nature, 461, 225-229.
6. Eulalio, A., Behm-Ansmant, I., Schweizer, D. and Izaurralde, E. (2007) P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol. Cell. Biol., 27, 3970-3981.
7. Parrish, S., Resch, W. and Moss, B. (2007) Vaccinia virus D10 protein has mRNA decapping activity, providing a mechanism for control of host and viral gene expression. Proc. Natl Acad. Sci. USA, 104, 2139-2144.
8. Wang, Z., Jiao, X., Carr-Schmid, A. and Kiledjian, M. (2002) The hDcp2 protein is a mammalian mRNA decapping enzyme. Proc. Natl Acad. Sci. USA, 99, 12663-12668.
9. Gunawardana, D., Cheng, H. C. and Gayler, K. R. (2008) Identification of functional domains in Arabidopsis thaliana mRNA decapping enzyme (AtDcp2). Nucleic Acids Res., 36, 203-216.
10. She, M., Decker, C. J., Chen, N., Tumati, S., Parker, R. and Song, H. (2006) Crystal structure and functional analysis of Dcp2p from Schizosaccharomyces pombe. Nat. Struct. Mol. Biol., 13, 63-70.
11. Parrish, S. and Moss, B. (2007) Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses. J. Virol., 81, 12973-12978.
12. Parrish, S., Hurchalla, M., Liu, S. W. and Moss, B. (2009) The African swine fever virus g5R protein possesses mRNA decapping activity. Virology, 393, 177-182.
13. Scarsdale, J. N., Peculis, B. A. and Wright, H. T. (2006) Crystal structures of U8 snoRNA decapping nudix hydrolase, X29, and its metal and cap complexes. Structure, 14, 331-343.
14. Mitchell, P. and Tollervey, D. (2000) mRNA stability in eukaryotes. Curr. Opin. Genet. Dev., 10, 193-198.
15. Caponigro, G. and Parker, R. (1996) Mechanisms and control of mRNA turnover in Saccharomyces cerevisiae. Microbiol. Rev., 60, 233-249.
16. Mildvan, A. S., Xia, Z., Azurmendi, H. F., Saraswat, V., Legler, P. M., Massiah, M. A., Gabelli, S. B., Bianchet, M. A., Kang, L. W. and Amzel, L. M. (2005) Structures and mechanisms of Nudix hydrolases. Arch. Biochem. Biophys., 433, 129-143.
17. Dunckley, T. and Parker, R. (1999) The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J., 18, 5411-5422.
18. Van Dijk, E., Cougot, N., Meyer, S., Babajko, S., Wahle, E. and Seraphin, B. (2002) Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J., 21, 6915-6924.
19. Lykke-Andersen, J. (2002) Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol. Cell. Biol., 22, 8114-8121.
20. 0-capped mRNA by a cap-modifying enzyme. Mol. Cell., 1, 443-447.
21. Tomoo, K., Shen, X., Okabe, K., Nozoe, Y., Fukuhara, S., Morino, S., Sasaki, M., Taniguchi, T., Miyagawa, H., Kitamura, K. et al. (2003) Structural features of human initiation factor 4E, studied by X-ray crystal analyses and molecular dynamics simulations. J. Mol. Biol., 328, 365-383.
22. Calero, G., Wilson, K. F., Ly, T., Rios-Steiner, J. L., Clardy, J. C. and Cerione, R. A. (2002) Structural basis of m7GpppG binding to the nuclear cap-binding protein complex. Nat. Struct. Biol., 9, 912-917.
23. Mazza, C., Segref, A., Mattaj, I. W. and Cusack, S. (2002) Co-crystallization of the human nuclear cap-binding complex with a m7GpppG cap analogue using protein engineering. Acta Crystallogr. D Biol. Crystallogr., 58, 2194-2197.
24. She, M., Decker, C. J., Svergun, D. I., Round, A., Chen, N., Muhlrad, D., Parker, R. and Song, H. (2008) Structural basis of dcp2 recognition and activation by dcp1. Mol. Cell, 29, 337-349.
25. Parrish, S. and Moss, B. (2006) Characterization of a vaccinia virus mutant with a deletion of the D10R gene encoding a putative negative regulator of gene expression. J. Virol., 80, 553-561.
26. Souliere, M. F., Perreault, J. P. and Bisaillon, M. (2009) Characterization of the vaccinia virus D10 decapping enzyme provides evidence for a two-metal-ion mechanism. Biochem. J., 420, 27-35.
27. Schwede, T., Kopp, J., Guex, N. and Peitsch, M. C. (2003) SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res., 31, 3381-3385.
28. Humphrey, W., Dalke, A. and Schulten, K. (1996) VMD: visual molecular dynamics. J Mol Graph, 14, 33-38.
29. Mayo, S. L., Olafson, B. D. and Goddard, W. A. (1990) DREIDING: a generic force field for molecular simulations. J. Phys. Chem., 94, 8897-8909.
30. Stewart, J. J. (2007) Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. J. Mol. Model, 13, 1173-1213.
31. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K. and Olson, A. J. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem., 19, 1639-1661.
32. Solis, F. J. and Wets, R. J. B. (1981) Minimization by random search techniques. Math. Oper. Res., 6, 19-30.
33. Quiocho, F. A., Hu, G. and Gershon, P. D. (2000) Structural basis of mRNA cap recognition by proteins. Curr. Opin. Struct. Biol., 10, 78-86.
34. Despins, S., Issur, M., Bougie, I. and Bisaillon, M. (2010) Deciphering the molecular basis for nucleotide selection by the West Nile virus RNA helicase. Nucleic Acids Res., [Epub ahead of print 25 April 2010] 10. 1093/nar/gkq276.
35. Issur, M., Despins, S., Bougie, I. and Bisaillon, M. (2009) Nucleotide analogs and molecular modeling studies reveal key interactions involved in substrate recognition by the yeast RNA triphosphatase. Nucleic Acids Res., 37, 3714-3722.
36. Nobeli, I., Laskowski, R. A., Valdar, W. S. and Thornton, J. M. (2001) On the molecular discrimination between adenine and guanine by proteins. Nucleic Acids Res., 29, 4294-4309.
37. Deshmukh, M. V., Jones, B. N., Quang-Dang, D. U., Flinders, J., Floor, S. N., Kim, C., Jemielity, J., Kalek, M., Darzynkiewicz, E. and Gross, J. D. (2008) mRNA decapping is promoted by an RNA-binding channel in Dcp2. Mol. Cell, 29, 324-336.
38. Souliere, M. F. and Bisaillon, M. (2008) Structures and mechanisms of Dcp2-like decapping enzymes. Curr. Top. Biochem. Res., 10, 55-62.
39. Shors, T., Keck, J. G. and Moss, B. (1999) Down regulation of gene expression by the vaccinia virus D10 protein. J. Virol., 73, 791-796.
40. Cohen, L. S., Mikhli, C., Jiao, X., Kiledjian, M., Kunkel, G. and Davis, R. E. (2005) Dcp2 Decaps m2, 2, 7GpppN-capped RNAs, and its activity is sequence and context dependent. Mol. Cell. Biol., 25, 8779-8791.
41. Di Bisceglie, A. M., Conjeevaram, H. S., Fried, M. W., Sallie, R., Park, Y., Yurdaydin, C., Swain, M., Kleiner, D. E., Mahaney, K. and Hoofnagle, J. H. (1995) Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med., 123, 897-903.
42. Leyssen, P., Balzarini, J., De Clercq, E. and Neyts, J. (2005) The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J. Virol., 79, 1943-1947.
43. Reardon, J. E. and Spector, T. (1989) Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. J. Biol. Chem., 264, 7405-7411.
44. Kamiya, N. (2003) The mechanisms of action of antivirals against hepatitis B virus infection. J. Antimicrob. Chemother., 51, 1085-1089.